Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

CD70 is downregulated by interaction with CD27.

Kuka M, Munitic I, Giardino Torchia ML, Ashwell JD.

J Immunol. 2013 Sep 1;191(5):2282-9. doi: 10.4049/jimmunol.1300868. Epub 2013 Aug 2.

2.

T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs.

Burchill MA, Tamburini BA, Kedl RM.

Eur J Immunol. 2015 Nov;45(11):3140-9. doi: 10.1002/eji.201545749. Epub 2015 Aug 3.

3.

CD8+ T cells produce the chemokine CXCL10 in response to CD27/CD70 costimulation to promote generation of the CD8+ effector T cell pool.

Peperzak V, Veraar EA, Xiao Y, Babala N, Thiadens K, Brugmans M, Borst J.

J Immunol. 2013 Sep 15;191(6):3025-36. doi: 10.4049/jimmunol.1202222. Epub 2013 Aug 12.

4.

Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology.

Nolte MA, van Olffen RW, van Gisbergen KP, van Lier RA.

Immunol Rev. 2009 May;229(1):216-31. doi: 10.1111/j.1600-065X.2009.00774.x. Review.

PMID:
19426224
5.

Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.

Arimoto-Miyamoto K, Kadowaki N, Kitawaki T, Iwata S, Morimoto C, Uchiyama T.

Immunology. 2010 May;130(1):137-49. doi: 10.1111/j.1365-2567.2010.03220.x. Epub 2010 Feb 26.

6.

Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway.

Coquet JM, Ribot JC, Bąbała N, Middendorp S, van der Horst G, Xiao Y, Neves JF, Fonseca-Pereira D, Jacobs H, Pennington DJ, Silva-Santos B, Borst J.

J Exp Med. 2013 Apr 8;210(4):715-28. doi: 10.1084/jem.20112061. Epub 2013 Apr 1.

7.

Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions.

Beishuizen CR, Kragten NA, Boon L, Nolte MA, van Lier RA, van Gisbergen KP.

J Immunol. 2009 Nov 15;183(10):6442-51. doi: 10.4049/jimmunol.0901565. Epub 2009 Oct 28.

8.

Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.

Hintzen RQ, Lens SM, Lammers K, Kuiper H, Beckmann MP, van Lier RA.

J Immunol. 1995 Mar 15;154(6):2612-23.

PMID:
7876536
9.

CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection.

Welten SP, Redeker A, Franken KL, Benedict CA, Yagita H, Wensveen FM, Borst J, Melief CJ, van Lier RA, van Gisbergen KP, Arens R.

J Virol. 2013 Jun;87(12):6851-65. doi: 10.1128/JVI.03305-12. Epub 2013 Apr 10.

10.

Opposing effects of CD70 costimulation during acute and chronic lymphocytic choriomeningitis virus infection of mice.

Penaloza-MacMaster P, Ur Rasheed A, Iyer SS, Yagita H, Blazar BR, Ahmed R.

J Virol. 2011 Jul;85(13):6168-74. doi: 10.1128/JVI.02205-10. Epub 2011 Apr 20.

11.

Thymus-derived regulatory T cells restrain pro-inflammatory Th1 responses by downregulating CD70 on dendritic cells.

Dhainaut M, Coquerelle C, Uzureau S, Denoeud J, Acolty V, Oldenhove G, Galuppo A, Sparwasser T, Thielemans K, Pays E, Yagita H, Borst J, Moser M.

EMBO J. 2015 May 12;34(10):1336-48. doi: 10.15252/embj.201490312. Epub 2015 Mar 18.

12.

CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.

Al Sayed MF, Ruckstuhl CA, Hilmenyuk T, Claus C, Bourquin JP, Bornhauser BC, Radpour R, Riether C, Ochsenbein AF.

Blood. 2017 Jul 20;130(3):297-309. doi: 10.1182/blood-2016-12-756585. Epub 2017 May 11.

PMID:
28495792
13.

The CD27-CD70 pathway and pathogenesis of autoimmune disease.

Han BK, Olsen NJ, Bottaro A.

Semin Arthritis Rheum. 2016 Feb;45(4):496-501. doi: 10.1016/j.semarthrit.2015.08.001. Epub 2015 Aug 11. Review.

PMID:
26359318
14.

Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses.

Kurche JS, Burchill MA, Sanchez PJ, Haluszczak C, Kedl RM.

J Immunol. 2010 Aug 15;185(4):2106-15. doi: 10.4049/jimmunol.1000172. Epub 2010 Jul 16.

15.

Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting.

Keller AM, Xiao Y, Peperzak V, Naik SH, Borst J.

Blood. 2009 May 21;113(21):5167-75. doi: 10.1182/blood-2008-03-148007. Epub 2009 Mar 11.

16.

CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.

Polak ME, Newell L, Taraban VY, Pickard C, Healy E, Friedmann PS, Al-Shamkhani A, Ardern-Jones MR.

J Invest Dermatol. 2012 Jun;132(6):1636-44. doi: 10.1038/jid.2012.26. Epub 2012 Mar 1.

17.

Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity.

Keller AM, Schildknecht A, Xiao Y, van den Broek M, Borst J.

Immunity. 2008 Dec 19;29(6):934-46. doi: 10.1016/j.immuni.2008.10.009. Epub 2008 Dec 8.

19.

The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans.

Hashimoto-Okada M, Kitawaki T, Kadowaki N, Iwata S, Morimoto C, Hori T, Uchiyama T.

Int Immunol. 2009 Aug;21(8):891-904. doi: 10.1093/intimm/dxp056. Epub 2009 Jun 25.

20.

CD27 and CD70 in T cell and B cell activation.

Borst J, Hendriks J, Xiao Y.

Curr Opin Immunol. 2005 Jun;17(3):275-81. Review.

PMID:
15886117

Supplemental Content

Support Center